Results are expressed as mean S
Results are expressed as mean S.D. inhibition in cell migration and invasiveness. These findings were extended to an model, by demonstrating that this stable knockdown of PKC using lentiviral shRNAs markedly impaired the metastatic potential of MDA-MB-231 breast cancer cells. Taken together, our findings unveil an unforeseen regulatory pathway comprising PKC and ZEB1 that promotes the activation of the EMT in breast malignancy cells. and models. Materials and Methods Cell Lines and Cell Culture Cells used in this study were obtained from ATCC. Edonerpic maleate MCF-10A cells were cultured in Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12) (Thermo Scientific) supplemented with 5% equine serum (GIBCO), 1% penicillin-streptomycin (GIBCO), 20 ng/ml EGF (Sigma-Aldrich), 10 g/ml insulin (Sigma-Aldrich), 0.5 mg/ml hydrocortisone (Sigma-Aldrich) and 100 ng/ml cholera toxin (Calbiochem). MCF-7 and T47-D cells were cultured in RPMI (GIBCO) supplemented with 10% fetal bovine serum (FBS; GIBCO), 1% L-glutamine (GIBCO) and 1% penicillin-streptomycin (GIBCO). NMuMG-NZEB1 and NMuMG-Vector cell lines were cultured in DMEM supplemented with 10% FBS, 1% L-glutamine, and 400 g/ml G418 (Sigma-Aldrich). Other cell lines (HEK-293T; BT-549; MDA-MB-231; MDA-MB-468; SKBR-3; MDA-MB-361 and BT-474) were cultured in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin. All the cell lines used in this work were unfavorable for mycoplasma contamination. Stable Cell Lines Generation NMuMG epithelial cells were transfected with eGFP-NZEB1 or eGFP-C3 vacant vector (EV), using lipofectamine 2000 (Invitrogen) according to the manufacturer’s Edonerpic maleate instructions, followed by 10 days selection with geneticin (G418, Sigma-Aldrich). Two rounds of cell sorting for GFP-positive cells were performed after antibiotic selection (FACS Aria II, BD Bioscience). Stable knockdown of PKC in MDA-MB-231 cells was achieved by transduction using the PLKO system of lentiviral shRNA-PKC (Dharmacon) or shRNA-NTC as a control. Selection of stable cell lines was carried out with puromycin (2 g/ml, Santa Cruz) for 10 days. DNA Constructs, shRNA, and RNAi The full-length rat ZEB1 cDNA (21) was subcloned into pcDNA4/HisMaxB (Invitrogen) (ZEB1-FL). ZEB1 deletion mutants ZD1-HD Edonerpic maleate and eGFP-NZEB1 were subcloned by into pcDNAI/Amp vector (Invitrogen) or eGFP-C3 (Clontech), Rabbit Polyclonal to Cytochrome P450 26C1 respectively. Full-length ZEB1 and ZEB1 deletion mutants were a kind gift from Dr. Douglas S. Darling (University of Louisville, USA). The E-cadherin luciferase promoter was a kind gift from Dr. Frans Van Roy (University of Ghent, Belgium) (58). All constructs were verified by sequencing. RNAi duplexes were purchased from Dharmacon (PKC1: CCAUCCGCUCCACACUAAA; PKC2: GAACAACAAGGAAUGACUU; PKC3: UAAGGAACCACAAGCAGUA; PKC4: UUAUAGGGAUCUGAAGUUA; PKC5: GAAGGGUUCUCGUAUGUCA; PKC6: UCACUGCUCUAUGGACUUA; ZEB1#1: CUGUAAGAGAGAAGCGGAA; ZEB1#2: CUGAAAUCCUCUCGAAUGA; ZEB1#3: GCGCAAUAACGUUACAAAU; ZEB1#4 GCAACAGGGAGAAUUAUUA; NTC: UGGUUUACAUGUUUUCUGA). shRNAs were purchased from Dharmacon (PKC: 1 TRCN1691; Edonerpic maleate 2 TRCN1692; 3 TRCN1693) (ZEB1: Z1 TRCN17563; Z2 TRCN17565; Z3 TRCN17566), shNTC-pLKO.1 was obtained from Addgene (ID#1864). Transfections and Lentiviral Contamination RNAi duplexes (25 nM) were transfected using Lipofectamine RNAiMAX (Thermo Fisher Scientific). HEK-293T cells were transfected to obtain virus particles using JetPrime (Polyplus-transfection) as recommended by the manufacturer. Stable knockdown of PKC in MDA-MB-231 was achieved by transduction using the PLKO system of lentiviral shRNA-PKC (Dharmacon) or shRNA-NTC as a control according to the manufacturer’s protocol. Analysis Prediction of potential ZEB1 phosphorylation sites was performed using by DISPHOS 1.3 KinasePhos and NetPhos 3.1 open source Web search tools (59C61). Luciferase Reporter Assays HEK-293T cells (5 104) were transfected by lipofection using PEI (PolyEthylenImine, Polysciences Inc.) Edonerpic maleate (62). We used 0.3 g of E-cadherin-Luc promoter and 0.3 g of CMV clone (-galactosidase reporter vector, Clontech) for normalization, which were co-transfected together with 0.5 g of ZEB1-FL or each ZEB1 deletion mutant (ZD1-HD or NZEB1). Luciferase and -galactosidase activities were evaluated as described (22). Results were.
